Chafetz Irwin increased its stake in Sands China (01928) by 1,623,200 shares, with a price of HK$13.83 per share.
After the increase, the latest number of shares held is approximately 6.071 billion shares, and the latest shareholding ratio is 75.01%.
According to the latest data from the Hong Kong Stock Exchange, on September 1st, Chafetz Irwin increased its stake in Sands China (01928) by 1,623,200 shares, at a price of HKD 13.83 per share, totaling approximately HKD 22,448,900. After the increase, the latest number of shares held is approximately 6.071 billion, with the latest holding percentage at 75.01%.
Related Party: Las Vegas Sands Corp.
Additional Information: From 18/08/2026 - 31/08/2026, 15,376,800 shares were purchased at an average price of HKD 14.36, increasing VVDI (II)'s shareholding from 74.80% to 74.99%. On 01/09/2026, 1,623,200 shares were purchased, further increasing its shareholding to 75.01%.
Related Articles
How to choose AI applications in Hong Kong stocks? DIAGENS-B (02526): A rare vertical AI target with high growth and strong barriers.
Valuation at $2 trillion! Anthropic may become the largest IPO in history, starting its roadshow in October and going public before the mid-term elections in November.
Astrazeneca PLC Sponsored ADR (AZN.US) has received accelerated approval from the FDA for a new breast cancer drug, and Wall Street estimates that sales could reach $2.3 billion by 2032.
How to choose AI applications in Hong Kong stocks? DIAGENS-B (02526): A rare vertical AI target with high growth and strong barriers.
Valuation at $2 trillion! Anthropic may become the largest IPO in history, starting its roadshow in October and going public before the mid-term elections in November.
Astrazeneca PLC Sponsored ADR (AZN.US) has received accelerated approval from the FDA for a new breast cancer drug, and Wall Street estimates that sales could reach $2.3 billion by 2032.
RECOMMEND
